Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKesson
Colorcon
McKinsey
Merck
Dow

Last Updated: December 6, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 200855

See Plans and Pricing

« Back to Dashboard

NDA 200855 describes LEUCOVORIN CALCIUM PRESERVATIVE FREE, which is a drug marketed by Am Regent, Fresenius Kabi Usa, Hospira, Mylan Labs Ltd, Sagent Pharms, Sagent Pharms Inc, Teva Parenteral, and West-ward Pharms Int, and is included in twelve NDAs. It is available from five suppliers. Additional details are available on the LEUCOVORIN CALCIUM PRESERVATIVE FREE profile page.

The generic ingredient in LEUCOVORIN CALCIUM PRESERVATIVE FREE is leucovorin calcium. There are nine drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the leucovorin calcium profile page.
Summary for 200855
Tradename:LEUCOVORIN CALCIUM PRESERVATIVE FREE
Applicant:Sagent Pharms
Ingredient:leucovorin calcium
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 200855
Medical Subject Heading (MeSH) Categories for 200855
Suppliers and Packaging for NDA: 200855
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
LEUCOVORIN CALCIUM PRESERVATIVE FREE leucovorin calcium INJECTABLE;INJECTION 200855 ANDA Sagent Pharmaceuticals 25021-816 25021-816-67 1 VIAL in 1 CARTON (25021-816-67) > 17.5 mL in 1 VIAL
LEUCOVORIN CALCIUM PRESERVATIVE FREE leucovorin calcium INJECTABLE;INJECTION 200855 ANDA Sagent Pharmaceuticals 25021-816 25021-816-30 1 VIAL in 1 CARTON (25021-816-30) > 17.5 mL in 1 VIAL

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 350MG BASE/VIAL
Approval Date:Sep 6, 2012TE:APRLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKesson
Medtronic
Baxter
Merck
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.